Meet the Minds Shaping the Future of Peptide Therapeutics

Hear directly from Europe's leading experts as they share the latest scientific advances, lessons learned and innovative strategies that are redefining peptide discovery, development and delivery.

Alexander McDermott, Senior Scientist in Peptide Chemistry at AstraZeneca and speaker at Peptide-Based Therapeutics Europe.

Alexander McDermott

Nicholas Morely, Associate Director of Analytical Science CMC at Bicycle Therapeutics plc.

Nicholas Morely

Hitesh Verma, Senior Project Manager at Boehringer Ingelheim and conference speaker.

Hitesh Verma

Rab Prinjha, Chief Research and Development Officer at Curve Therapeutics.

Rab Prinjha

Florian Foeger, Founder and Chief Executive Officer of CYPRUMED.

Florian Foeger

Gilles Divita, Chief Executive Officer of Divincell and peptide therapeutics speaker.

Gilles Divita

Christian Heinis, Associate Professor at EPFL specialising in peptide engineering.

Christian Heinis

David Guay, Vice President of Innovation and Technology at Feldan Therapeutics.

David Guay

Pius Baur, Scientific Director at Johnson & Johnson and conference speaker.

Pius Baur

Luca Gambini, Principal Scientist Discovery Chemistry at Johnson & Johnson.

Luca Gambini

Riet Dams, VP and Global Head of Drug Product Research and Development at Johnson & Johnson.

Riet Dams

Philip Sassene, Scientific Director at Novo Nordisk and peptide therapeutics expert.

Philip Sassene

Morten Graugaard, Chief Executive Officer at Orbis Medicines.

Morten Graugaard

Sevan Habeshian, Co-Founder and Vice President of Platform Chemistry at Orbis Medicines.

Sevan Habeshian

Ali Tavassoli, Professor of Chemical Biology at the University of Southampton.

Ali Tavassoli

Dhira Joshi, Deputy Head of Peptide Chemistry at The Francis Crick Institute.

Dhira Joshi

Daniella Hares, Computational Chemist at The Francis Crick Institute.

Daniella Hares

Yew Mun Yip, Computational Chemistry Expert at The Francis Crick Institute.

Yew Mun Yip

David Brayden, Professor of Advanced Drug Delivery at University College Dublin.

David Brayden

Jody Mason, Chief Scientific Officer at Revolver Therapeutics and Professor of Biochemistry.

Jody Mason

Thomas Von Erlach, Co-Founder and Chief Executive Officer of Vivtex Corp.

Thomas Von Erlach

Federico Chiaro, Senior Manager of CMC Projects at Zealand Pharma A/S.

Federico Chiaro

Peptide-Based Therapeutics Europe Scientific Presentation

Join Europe's Peptide Community

Secure your place and connect with the scientists shaping the next generation of peptide therapeutics.

Industry expert presenting on peptide therapeutics and drug development at Peptide-Based Therapeutics Europe.

Share Your Science

Apply to speak and showcase your latest innovations alongside Europe's leading peptide experts.

Attendees networking at Peptide-Based Therapeutics Europe conference for peptide drug discovery and pharmaceutical innovation.

Partner with Industry Leaders

Position your organisation at the heart of Europe's peptide ecosystem and connect with the decision-makers driving innovation.